Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: Dantari, Apogee and more
As venture capital pours into budding biotechs, we're launching the Fierce Biotech Fundraising Tracker to keep tabs on all things financing.
Max Bayer
,
Gabrielle Masson
Dec 8, 2022 10:11am
Vial reels in $67M in series B fund raising; adds NEXT Oncology
Nov 30, 2022 3:11pm
Sanofi-backed Escient bags $120M series C
Nov 28, 2022 11:06am
AbbVie links up with VC firm to map anti-inflammatory companies
Nov 28, 2022 7:30am
NewAmsterdam takes SPAC route to fund phase 3 trials
Nov 23, 2022 9:29am
Jnana Therapeutics brings in $107M funds, $2B Roche collab
Nov 15, 2022 6:00am
